HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

AbstractBACKGROUND:
Initial hypotheses regarding the role of the kappa opioid system in drug addiction suggested that kappa receptor stimulation had anti-addictive effects. However, recent research suggests that kappa receptor antagonists may reverse motivational aspects of dependence. In the present review, we revisit the studies that measured the effects of kappa receptor ligands on the reinforcing and rewarding effects of drugs and postulate underlying neurobiological mechanisms for these effects to elaborate a more complex view of the role of kappa receptor ligands in drug addiction.
RESULTS:
The review of studies indicates that kappa receptor stimulation generally antagonizes the acute reinforcing/rewarding effects of drugs whereas kappa receptor blockade has no consistent effect. However, in a drug dependent-like state, kappa receptor blockade was effective in reducing increased drug intake. In animal models of reinstatement, kappa receptor stimulation can induce reinstatement via a stress-like mechanism. Results in conditioned place preference/aversion and intracranial self-stimulation indicate that kappa receptor agonists produce, respectively, aversive-like and dysphoric-like effects. Additionally, preclinical and postmortem studies show that administration or self-administration of cocaine, ethanol, and heroin activate the kappa opioid system.
CONCLUSION:
kappa receptor agonists antagonize the reinforcing/rewarding effects of drugs possibly through punishing/aversive-like effects and reinstate drug seeking through stress-like effects. Evidence suggests that abused drugs activate the kappa opioid system, which may play a key role in motivational aspects of dependence. Kappa opioid systems may have an important role in driving compulsive drug intake.
AuthorsSunmee Wee, George F Koob
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 210 Issue 2 Pg. 121-35 (Jun 2010) ISSN: 1432-2072 [Electronic] Germany
PMID20352414 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Analgesics, Opioid
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • Dynorphins
Topics
  • Analgesics, Opioid (pharmacology)
  • Animals
  • Chronic Disease
  • Drug Tolerance
  • Dynorphins (physiology)
  • Humans
  • Receptors, Opioid, kappa (agonists, antagonists & inhibitors, physiology)
  • Receptors, Opioid, mu (agonists)
  • Reinforcement, Psychology
  • Reward
  • Self Administration
  • Substance-Related Disorders (metabolism, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: